Changes in Mifepristone Use at Pharmacies After Removal of the FDA In-Person Dispensing Requirement

Key Points

• This study aims to evaluate how the removal of the FDA’s in-person dispensing requirement affects access to mifepristone.
• Cross-sectional design
• Assessment of retail and mail-order pharmacy access
• Comparison before and after the FDA policy change
• Increased availability of mifepristone at retail pharmacies
• Growth in mail-order pharmacy access
• Greater overall access to medication after policy modification

Abstract